Arkadios Wealth Advisors’s Repligen RGEN Stock Holding History

Arkadios Wealth Advisors’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-18	Closed	-$3K	–	2019
2021 Q1	$3K	Buy	+18	New	+$3.69K	﹤0.01%	1477

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Arkadios Wealth Advisors's RGEN Position: Q2 2021 in Review

Arkadios Wealth Advisors sold out of Repligen (RGEN) in Q2 2021, closing a stake of 18 shares — an estimated $3K sold.

Arkadios Wealth Advisors first reported a position in RGEN in Q1 2021 and held it in 1 quarter. The position peaked at $3K in Q1 2021. 428 funds tracked by Wall St. Rank hold RGEN as of Q2 2021.

Arkadios Wealth Advisors reported no remaining Repligen position as of Q2 2021 after selling out during the quarter.
Arkadios Wealth Advisors sold 18 Repligen shares in Q2 2021, an estimated $3K.
Arkadios Wealth Advisors first reported a position in Repligen in Q1 2021 and held it in 1 quarter.
Arkadios Wealth Advisors's Repligen position peaked at $3K in Q1 2021.
428 funds tracked by Wall St. Rank held Repligen as of Q2 2021.

Based on Arkadios Wealth Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.